237 related articles for article (PubMed ID: 19091226)
21. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
22. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor.
Hernàndez DE; Hernàndez AE
Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909
[TBL] [Abstract][Full Text] [Related]
23. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
[TBL] [Abstract][Full Text] [Related]
24. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
25. [HIV-related multiple non-Hodgkin lymphomas].
Gotoh M; Kitahara T; Iguchi T; Izumi M; Mukai K; Ohyashiki K
Rinsho Ketsueki; 2008 Nov; 49(11):1552-5. PubMed ID: 19047787
[TBL] [Abstract][Full Text] [Related]
26. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma.
Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T
Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317
[No Abstract] [Full Text] [Related]
27. Tumor melt: primary effusion lymphoma of the heart.
Kriekard P; Garcia JA; Nardi-Korver L; Krantz MJ
Am J Med; 2012 Sep; 125(9):e5-6. PubMed ID: 22682793
[No Abstract] [Full Text] [Related]
28. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D
J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005
[TBL] [Abstract][Full Text] [Related]
29. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
[No Abstract] [Full Text] [Related]
30. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
31. [AIDS and non-Hodgkin's lymphoma: initial cardiac manifestations of highly malignant B-cell lymphoma 18 years after HIV infection].
Sturm A; Noppeney R; Reimer J; Ross B; Baumgart D; Sundermann T; Sadony V; Gerken G
Dtsch Med Wochenschr; 2001 Mar; 126(13):364-6. PubMed ID: 11332231
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous diffuse large B cell lymphoma, leg type.
Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
[No Abstract] [Full Text] [Related]
33. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Dillon R; Hirschfield GM; Allison ME; Rege KP
BMJ; 2008 Jul; 337():a423. PubMed ID: 18595895
[No Abstract] [Full Text] [Related]
34. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Fabbri A; Gozzetti A; Rigacci L
Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
[No Abstract] [Full Text] [Related]
35. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Little RF; Pittaluga S; Grant N; Steinberg SM; Kavlick MF; Mitsuya H; Franchini G; Gutierrez M; Raffeld M; Jaffe ES; Shearer G; Yarchoan R; Wilson WH
Blood; 2003 Jun; 101(12):4653-9. PubMed ID: 12609827
[TBL] [Abstract][Full Text] [Related]
36. [Primary hepatic non-Hodgkin's lymphoma].
De la Maya MD; Escalante R; Torre A; Urdambidelus C
Sangre (Barc); 1999 Jun; 44(3):242. PubMed ID: 10481592
[No Abstract] [Full Text] [Related]
37. Hidden superpower.
McGuirt J
JAAPA; 2019 May; 32(5):66. PubMed ID: 31033720
[No Abstract] [Full Text] [Related]
38. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
39. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Osorio S; Bernis C; de La Cámara R
Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
[No Abstract] [Full Text] [Related]
40. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response.
Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L
J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]